Gene · 55872
Papers1,726
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,726
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| E2F3 renders an immunosuppressive tumor microenvironment in nasopharyngeal carcinoma: Involvements of the transcription activation of PRC1 and BIRC5. | Immun Inflamm Dis | 2023 | 37647439 | PubTator, text mining | PubMed |
| A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG. | BMC Cancer | 2023 | 37644431 | PubTator, text mining | PubMed |
| Approach strategies and application of metabolomics to biotechnology in plants. | Front Plant Sci | 2023 | 37636096 | PubTator, text mining | PubMed |
| Polyphyllin VII induces autophagy-dependent ferroptosis in human gastric cancer through targeting T-lymphokine-activated killer cell-originated protein kinase. | Phytother Res | 2023 | 37632389 | PubTator, text mining | PubMed |
| An Immune-Related Gene Signature for Predicting Survival and Immunotherapy Efficacy in Esophageal Adenocarcinoma. | Med Sci Monit | 2023 | 37632137 | PubTator, text mining | PubMed |
| Multi-Task Time Series Forecasting Based on Graph Neural Networks. | Entropy (Basel) | 2023 | 37628166 | PubTator, text mining | PubMed |
| The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma. | Sci Rep | 2023 | 37626132 | PubTator, text mining | PubMed |
| Predicting the molecular mechanism-driven progression of breast cancer through comprehensive network pharmacology and molecular docking approach. | Sci Rep | 2023 | 37607964 | PubTator, text mining | PubMed |
| Impaired Plakophilin-2 in obesity breaks cell cycle dynamics to breed adipocyte senescence. | Nat Commun | 2023 | 37607954 | PubTator, text mining | PubMed |
| Topical application of TOPK inhibitor OTS514 suppresses psoriatic progression by inducing keratinocytes cell cycle arrest and apoptosis. | Exp Dermatol | 2023 | 37578092 | PubTator, text mining | PubMed |
| Preliminary Phytochemical and Biological Evaluation of Rudbeckia hirta Flowers. | Plants (Basel) | 2023 | 37571024 | PubTator, text mining | PubMed |
| Comprehensive analysis of CXCL14 uncovers its role during liver metastasis in colon cancer. | BMC Gastroenterol | 2023 | 37563546 | PubTator, text mining | PubMed |
| Identification and validation of a novel anoikis-related signature for predicting prognosis and immune landscape in ovarian serous cystadenocarcinoma. | Heliyon | 2023 | 37554782 | PubTator, text mining | PubMed |
| Identification of PDCL2 as a candidate marker in Sertoli cell-only syndrome by chromatin immunoprecipitation-sequencing and bioinformatics analysis. | Transl Androl Urol | 2023 | 37554526 | PubTator, text mining | PubMed |
| Wavelet gated multiformer for groundwater time series forecasting. | Sci Rep | 2023 | 37543689 | PubTator, text mining | PubMed |
| Transcriptional signatures measured in whole blood correlate with protection against tuberculosis in inbred and outbred mice. | PLoS One | 2023 | 37535648 | PubTator, text mining | PubMed |
| The cervical transcriptome changes during the menstrual cycle but does not predict the window of implantation. | Front Reprod Health | 2023 | 37519341 | PubTator, text mining | PubMed |
| Evaluation and Comparison of Dermo-Cosmetic Activities of Three Oak Species by Targeting Antioxidant Metabolites and Skin Enzyme Inhibitors. | Metabolites | 2023 | 37512511 | PubTator, text mining | PubMed |
| Identification by Exome Sequencing of Predisposing Variants in Familial Cases of Autoinflammatory Recurrent Fevers. | Genes (Basel) | 2023 | 37510214 | PubTator, text mining | PubMed |
| Methylseleninic acid overcomes gefitinib resistance through asparagine-MET-TOPK signaling axis in non-small cell lung cancer cells. | Biochem Pharmacol | 2023 | 37481142 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55872/papers?page=11